Back to top

Mirum Pharmaceuticals (MIRM) Analyst Rating Update: Price Target Raised to $80 | MIRM Stock News

Mirum Pharmaceuticals (MIRM) Analyst Rating Update: Price Target Raised to $80 | MIRM Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Mirum Pharmaceuticals, Inc. (MIRM)